Close this search box.

10 years Pivot Park: ImmunoPrecise

Pivot Park was founded 10 years ago in 2012 and to mark the first decade of this, we asked several tenants who have been with us since the beginning. They talk about their successes, how to contribute to our ambition to improve global health care and what they expect from the upcoming 10 years. In the upcoming weeks, we will share their stories with you and we kick off with ImmunoPrecise

ImmunoPrecise’s core strength lies in its ability to quickly and efficiently adapt innovative antibody development technologies into novel therapies,” explains Debby Kruijsen who has been with the Pivot Park located company since 2012, first as a Researcher, now as General Manager. Providing scientific services is like a good restaurant, delivery of high quality is crucial
to ensure returning customers.

Providing scientific services is like a good restaurant, delivery of high quality is crucial to esnure returning customers

“Antibodies are an important part of the human immune system,” explains Kruijsen. “They are produced by the immune system in response to invasive antigens (foreign molecules). When the antibodies to a particular infection are developed, memory cells are also produced. The latter remain in the body for years and are a robust defence against repeated infection. This memory mechanism protects the body without having to continuously going through the process to initiate the development of all kinds of antibodies. With the proper research and knowledge, you can utilise and stimulate those antibodies. For example, in the case of cancer, you can use them to activate so-called ‘killer cells’, which fight and ultimately kill the cancer cells.”

“We aren’t just developing technologies to produce specific antibodies outside the human body. We’re also translating new technologies into the generation of therapeutics. We can assess at an early stage whether therapeutics are effective or not. It’s about tackling that process right from the beginning all the way to the start of clinical trials.”

ImmunoPrecise is a Contract Research Organization (CRO) that keeps up with all the latest developments in its field. The company works together with various international pharmaceutical companies and universities.

ImmunoPrecise is always looking for possibilities to expand its portfolio to develop antibodies against novel targets in a broad range of diseases, such as immuno-oncology, infectious diseases and rare diseases. The company started as a spin-off from the Radboud University. Kruijsen said, “When Pivot Park started as a life science park, we moved our laboratories to Oss, at that time known as Modiquest Research. We grew very rapidly. In 2018 we were acquired by ImmunoPrecise and renamed into ImmunoPrecise Antibodies in 2019.”

“Reputations in science are like reviews of a good restaurant,” says Kruijsen. “If you exceed expectations and deliver quality you build a relationship with a partner to develop more novel therapeutic antibodies. Afterwards, maintaining the delivery of high quality is crucial. Soon we will move into part of the new development here at Pivot Park. We want to further expand our service package to independently develop therapeutic antibodies from target antigen to clinical validation. The knowledge about immunology in the Netherlands is first rate, and we facilitate and stimulate its growth through partnerships and our own research.” Kruijsen foresees a doubling of the ImmunoPrecise location at Pivot Park over the next ten years, forecasting twice as many staff housed in twice as much space.

ImmunoPrecise - Debby Kruijsen-Vermeer

ImmunoPrecise develops technologies to efficiently develop therapeutic antibodies to treat a broad range of diseases. This Contract Research Organization (CRO) has offices in Europe (Oss and Utrecht) and North America.

Are you ready to make your mark and improve global health together as an innovator or as a service provider in the park? Join our community

Pivot Park Captains' Dinner

10 years ago, Pivot Park opened its doors to the world. Thanks to your commitment, support and confidence, we have been able to grow it into the successful and innovative biopharmaceutical campus it is today.

Now it’s time to celebrate!

We are therefore delighted to invite you – along with all your fellow CEOs at Pivot Park – to a special night out featuring inspiring art, a wonderful dinner and lots of opportunities to network and exchange ideas.

Erwin Wurm | Am I a House?

For the first time, the artist shows a cross-section of his work, from Narrow Furniture to One Minute Sculptures, within the walls of a historic building. Villa Constance, a former home that today houses Museum Jan Cunen, is not only a location but also part of the conversation. Because what exactly is a house?


The development of medicines in Oss began one hundred years ago. It was then that the foundations were laid for what would become a flourishing pharmaceutical sector in the Netherlands, leading to groundbreaking discoveries such as insulin and the anti-conception pill.

Today, the entire chain is still represented in Oss, from early-stage research to the commercial scale production of medicines. Working in Oss, we focus on the health of people all over the world. Employees at dozens of companies large and small put their heart and soul into new medicines, products and services that will improve lives worldwide. Together, our strength lies in our combination of broad knowledge about the development of medicines and a thorough understanding of the requirements of high-quality production.

This shared past and common values stimulate strong bonds among everyone who works in pharmaceuticals in Oss. We build on qualities, expertise and networks that go back decades. And with a wide variety of pharmaceutical companies, suppliers and scientific institutions all located nearby, we offer an attractive business climate and an excellent basis for international collaboration.

We are proud to work together to create a better and healthier future for all, a collaboration that in turn fuels growing employment: today, most pharmaceutical jobs in the Netherlands are in Oss. Here we connect talent and companies and stimulate entrepreneurship, while our expert employees are our most important asset. Their drive ensures that Oss has an influence on health all over the world.

Pharma in Oss offers endless opportunities to startups and talent in a city and region that is a joy to live and work in. We are committed to collaboration and sustainable and successful entrepreneurship. Oss’s pharmaceutical companies are intrinsically competitive while also being committed to quality and safety. This, plus their focus on new health solutions and contemporary technology, makes us a leader in our pursuit of a better life for people worldwide.